These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 37000176)

  • 21. Prediction of Oral Pharmacokinetics Using a Combination of In Silico Descriptors and In Vitro ADME Properties.
    Kosugi Y; Hosea N
    Mol Pharm; 2021 Mar; 18(3):1071-1079. PubMed ID: 33512165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of hepatic clearance prediction using in vitro data: emphasis on fraction unbound in plasma and drug ionisation using a database of 107 drugs.
    Hallifax D; Houston JB
    J Pharm Sci; 2012 Aug; 101(8):2645-52. PubMed ID: 22700322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between passive permeability, efflux, and predictability of clearance from in vitro metabolic intrinsic clearance.
    Huang L; Berry L; Ganga S; Janosky B; Chen A; Roberts J; Colletti AE; Lin MH
    Drug Metab Dispos; 2010 Feb; 38(2):223-31. PubMed ID: 19875499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Critically Assessing the Predictive Power of QSAR Models for Human Liver Microsomal Stability.
    Liu R; Schyman P; Wallqvist A
    J Chem Inf Model; 2015 Aug; 55(8):1566-75. PubMed ID: 26170251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro drug metabolism using liver microsomes.
    Hill JR
    Curr Protoc Pharmacol; 2004 Feb; Chapter 7():Unit7.8. PubMed ID: 21956813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intrinsic Clearance Assay Incubational Binding: A Method Comparison.
    Chen S; Prieto Garcia L; Bergström F; Nordell P; Grime K
    Drug Metab Dispos; 2017 Apr; 45(4):342-345. PubMed ID: 28122786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of human pharmacokinetics--evaluation of methods for prediction of hepatic metabolic clearance.
    Fagerholm U
    J Pharm Pharmacol; 2007 Jun; 59(6):803-28. PubMed ID: 17637173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel approach to perform metabolite screening during the quantitative LC-MS/MS analyses of in vitro metabolic stability samples using a hybrid triple-quadrupole linear ion trap mass spectrometer.
    Shou WZ; Magis L; Li AC; Naidong W; Bryant MS
    J Mass Spectrom; 2005 Oct; 40(10):1347-56. PubMed ID: 16206149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictions of the in vivo clearance of drugs from rate of loss using human liver microsomes for phase I and phase II biotransformations.
    Mohutsky MA; Chien JY; Ring BJ; Wrighton SA
    Pharm Res; 2006 Apr; 23(4):654-62. PubMed ID: 16550474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of human and animal liver microsomes in drug metabolic studies.
    Lacarelle B; Marre F; Blanc-Gauthier T; Zhou XJ; Placidi M; Catalin J; Rahmani R
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():458-65. PubMed ID: 1820923
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Morita K; Kato M; Kudo T; Ito K
    Xenobiotica; 2020 Sep; 50(9):1064-1075. PubMed ID: 32125203
    [No Abstract]   [Full Text] [Related]  

  • 32. An update on in vitro test methods in human hepatic drug biotransformation research: pros and cons.
    Brandon EF; Raap CD; Meijerman I; Beijnen JH; Schellens JH
    Toxicol Appl Pharmacol; 2003 Jun; 189(3):233-46. PubMed ID: 12791308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toward an integrated human clearance prediction strategy that minimizes animal use.
    Beaumont K; Gardner I; Chapman K; Hall M; Rowland M
    J Pharm Sci; 2011 Oct; 100(10):4518-35. PubMed ID: 21710508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicting clearance in humans from in vitro data.
    Obach RS
    Curr Top Med Chem; 2011; 11(4):334-9. PubMed ID: 21320062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utility of metabolic stability screening: comparison of in vitro and in vivo clearance.
    Clarke SE; Jeffrey P
    Xenobiotica; 2001; 31(8-9):591-8. PubMed ID: 11569527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of input parameters on the prediction of hepatic plasma clearance using the well-stirred model.
    Wan H; Bold P; Larsson LO; Ulander J; Peters S; Löfberg B; Ungell AL; Någård M; Llinàs A
    Curr Drug Metab; 2010 Sep; 11(7):583-94. PubMed ID: 20629632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [In vivo activity of drug-metabolizing enzymes in various pathological conditions].
    Krakovskiĭ ME; Ashirmetov AKh
    Vopr Med Khim; 1985; 31(1):76-9. PubMed ID: 3984279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro-in vivo correlation for drugs and other compounds eliminated by glucuronidation in humans: pitfalls and promises.
    Miners JO; Knights KM; Houston JB; Mackenzie PI
    Biochem Pharmacol; 2006 May; 71(11):1531-9. PubMed ID: 16455060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of human metabolic clearance from in vitro systems: retrospective analysis and prospective view.
    Hallifax D; Foster JA; Houston JB
    Pharm Res; 2010 Oct; 27(10):2150-61. PubMed ID: 20661765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data.
    Iwatsubo T; Hirota N; Ooie T; Suzuki H; Shimada N; Chiba K; Ishizaki T; Green CE; Tyson CA; Sugiyama Y
    Pharmacol Ther; 1997; 73(2):147-71. PubMed ID: 9131722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.